DaVita Aktie

154,96USD -0,18USD -0,12%
DaVita für 0 Euro bei ZERO ordern (zzgl. Spreads)
WKN: 897914 / ISIN: US23918K1088
<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Personal

2020 2021 2022 2023 2024
Personal am Ende des Jahres 67 000 69 000 70 000 70 000 76 000
Umsatz pro Mitarbeiter in Mio. EUR 0,17 0,17 0,17 0,17 0,17

Bilanz (in Mio. USD) - Aktiva

2020 2021 2022 2023 2024
Summe Umlaufvermögen 3 149 3 168 3 155 3 138 3 746
Summe Anlagevermögen 14 613 14 703 14 524 14 482 14 226
Summe Aktiva 17 762 17 871 17 680 17 619 17 972

Bilanz (in Mio. USD) - Passiva

2020 2021 2022 2023 2024
Summe Fremdkapital 14 865 15 500 15 455 14 876 15 881
Summe Eigenkapital 2 897 2 371 2 225 2 743 2 091
Summe Passiva 17 762 17 871 17 680 17 619 17 972

Adresse

2000 16th Street, 80202-7198 Denver
Telefon +1 (720) 631-2100
Internet http://www.davita.com

Management

Adam H. Schechter
Independent Director
Alan Cullop
Chief Information Officer
Andrew Mohraz
Associate General Counsel & Head-Investigations
Barbara Jean Desoer
Independent Non-Executive Director
Bruce E. Ware
Vice President
Charles G. Berg
Independent Director
Christopher M. Berry
Chief Accounting Officer
David P. Maughan
Chief Operating Officer
Dennis W. Pullin
Independent Director
Gregory J. Moore
Independent Director
James O. Hearty
Chief Compliance Officer
Jason M. Hollar
Independent Director
Javier J. Rodriguez
Chief Executive Officer & Director
Jeffrey A. Giullian
Chief Medical Officer-Kidney Care
Jeffrey Wagner
Senior Vice President
Jessica Hergenreter
Chief People Officer
Joel Ackerman
Chief Financial Officer & Treasurer
Kathleen Alyce Waters
Chief Legal & Public Affairs Officer
Madhu Narasimhan
Chief Information Officer
Mahesh Krishnan
Group Vice President-Growth
Michael D. Staffieri
Chief Operating Officer-Emeritus
Nic Eliason
Investor Relations Contact
Pamela M. Arway
Independent Chairman
Phyllis R. Yale
Independent Non-Executive Director
Samantha A. Caldwell
Secretary
Wendy Lee Schoppert
Independent Director